Effect of Exercise Pulmonary Rehabilitation on Long-Term Outcomes in Idiopathic Pulmonary Fibrosis

被引：0
|
作者：
Vainshelboim, Baruch [1 ]
Oliviera, Jose [2 ]
Yehoshua, Liora [1 ]
Fox, Benjamin D. [1 ]
Kramer, Mordechai R. [1 ]
机构：
[1] Beilinson Med Ctr, Rabin Med Ctr, Petah Tiqwa, Israel
[2] Univ Porto, Fac Sport, P-4100 Oporto, Portugal
来源：
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE | 2014年 / 46卷 / 05期
关键词：
D O I：
10.1249/01.mss.0000495084.47832.8c
中图分类号：
G8 [体育];
学科分类号：
04 ; 0403 ;
摘要：
1972
引用
收藏
页码：540 / 541
页数：3
相关论文
共 50 条
  • [41] Efficacy Of Long-Term Inhaled N-Acetylcysteine In Idiopathic Pulmonary Fibrosis
    Urabe, N.
    Sugino, K.
    Muramatsu, Y.
    Sato, K.
    Sakamoto, S.
    Takai, Y.
    Homma, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [42] LONG-TERM EFFICACY OF MACROLIDE TREATMENT IN IDIOPATHIC PULMONARY FIBROSIS: A RETROSPECTIVE ANALYSIS
    Kuse, Naoyuki
    Abe, Shinji
    Hayashi, Hiroki
    Kamio, Koichiro
    Saito, Yoshinobu
    Usuki, Jiro
    Azuma, Arata
    Kudoh, Shoji
    Gemma, Akihiko
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2016, 33 (03) : 242 - 246
  • [43] Safety and Efficacy of Early and Long-Term Use of Pirfenidone in Idiopathic Pulmonary Fibrosis
    Tzilas, Vasilios
    Tzouvelekis, Argyrios
    Bouros, Demosthenes
    RESPIRATION, 2019, 98 (01) : 16 - 18
  • [44] Six Patients Of Long-Term Survivor With Treatment Of Pirfenidone For Idiopathic Pulmonary Fibrosis
    Katano, T.
    Kitamura, H.
    Okuda, R.
    Yamakawa, H.
    Ikeda, S.
    Baba, T.
    Okudela, K.
    Takemura, T.
    Iwasawa, T.
    Komatsu, S.
    Hagiwara, E.
    Ogura, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [45] The long-term safety of pirfenidone (PFD) in patients with idiopathic pulmonary fibrosis (IPF)
    Valeyre, Dominique
    Albera, Carlo
    Bradford, Williamson
    Costabel, Ulrich
    King, Talmadge
    Noble, Paul
    Sahn, Steven
    du Bois, Roland
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [46] Comprehensive assessment of the long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosis
    Valeyre, Dominique
    Albera, Carlo
    Bradford, Williamson Z.
    Costabel, Ulrich
    King, Talmadge E., Jr.
    Leff, Jonathan A.
    Noble, Paul W.
    Sahn, Steven A.
    du Bois, Roland M.
    RESPIROLOGY, 2014, 19 (05) : 740 - 747
  • [47] The Efficacy and Safety Long-term Pirfenidone Therapy in Patients with Idiopathic Pulmonary Fibrosis
    Ogawa, Kazumasa
    Miyamoto, Atsushi
    Hanada, Shigeo
    Takahashi, Yui
    Murase, Kyoko
    Mochizuki, Sayaka
    Uruga, Hironori
    Takaya, Hisashi
    Morokawa, Nasa
    Kishi, Kazuma
    INTERNAL MEDICINE, 2018, 57 (19) : 2813 - 2818
  • [48] Pulmonary Outcomes Associated with Long-Term Azithromycin Therapy in Cystic Fibrosis
    Nichols, Dave P.
    Odem-Davis, Katherine
    Cogen, Jonathan D.
    Goss, Christopher H.
    Ren, Clement L.
    Skalland, Michelle
    Somayaji, Ranjani
    Heltshe, Sonya L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201 (04) : 430 - 437
  • [49] Exercise training in idiopathic pulmonary fibrosis
    Vainshelboim, Baruch
    Fox, Benjamin Daniel
    Oliveira, Jose
    Kramer, Mordechai Reuven
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2016, 10 (01) : 69 - 77
  • [50] Home-based pulmonary rehabilitation in idiopathic pulmonary fibrosis
    Rammaert, B.
    Leroy, S.
    Cavestri, B.
    Wallaert, B.
    Grosbois, J. -M.
    REVUE DES MALADIES RESPIRATOIRES, 2009, 26 (03) : 275 - 282
12345